In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy

Michelle D Kelsey; L Kristin Newby

doi:10.7326/ACPJ202012150-071

In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy

Ann Intern Med. 2020 Dec 15;173(12):JC71. doi: 10.7326/ACPJ202012150-071.

Authors

Michelle D Kelsey¹, L Kristin Newby¹

Affiliation

¹ Duke University, Durham, North Carolina, USA (M.D.K., L.K.N.).

PMID: 33316194
DOI: 10.7326/ACPJ202012150-071

Abstract

Hopewell JC, Offer A, Haynes R, et al. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. Eur Heart J. 2020;41:3336-42. 32702748.

Publication types

Comment

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Muscles
Muscular Diseases* / chemically induced
Risk Factors
Simvastatin / adverse effects

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin